Tremblay, G., Chandiwana, D., Dolph, M., Hearnden, J., Forsythe, A., & Monaco, M. (2018). Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer. Cancer Manag Res.
Stile di citazione ChicagoTremblay, Gabriel, David Chandiwana, Mike Dolph, Jaclyn Hearnden, Anna Forsythe, e Mauricio Monaco. "Matching-adjusted Indirect Treatment Comparison of Ribociclib and Palbociclib in HR+, HER2− Advanced Breast Cancer." Cancer Manag Res 2018.
Citazione MLATremblay, Gabriel, et al. "Matching-adjusted Indirect Treatment Comparison of Ribociclib and Palbociclib in HR+, HER2− Advanced Breast Cancer." Cancer Manag Res 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.